Annovis Bio, Inc. (ANVS) Misses Q3 EPS by 46c

Annovis Bio, Inc. (NYSE: ANVS) reported Q3 EPS of ($0.97), $0.46 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Annovis Bio, Inc. (ANVS) click here.

You May Also Be Interested In

• CFRA Starts SpaceX (SPCX) at Sell, 'Our primary concern is that SpaceX’s long-term strategy remains heavily dependent on Starship'
• In memo, Meta says it plans to crack down on employee token use as AI costs soar - The Information
• Precipio seeks shareholder votes to meet quorum for annual meeting